Gen 2 Battrode Wear Study | NCT07256951 | Trialant
RecruitingInterventionalNot ApplicableUpdated Dec 1, 2025
Gen 2 Battrode Wear Study
Gen 2 Battrode Wear Study
ClinicalTrials.gov ID
NCT07256951
Lead Sponsor
Baxter Healthcare CorporationINDUSTRY
Overall Status
Recruiting
Study Type
Interventional
Phase
Not Applicable
Enrollment
30Estimated
Last Update Posted
Dec 1, 2025Actual
Start Date
Nov 12, 2025Actual
Primary Completion Date
Dec 19, 2025Estimated
Completion Date
May 15, 2026Estimated
Official Title
Gen 2 Battrode Wear Study
Brief Summary
Validating adhesive wear time
Adhesive Wear Time
Adhesive
Ages Eligible for Study
Adult (18-64)Older Adult (65+)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
Yes
Eligibility Criteria
Inclusion Criteria:
Participant is ≥ 18 years.
Completes the consent process as required.
Participants can speak and read English fluently.
Willing to allow shaving of device application area, as required.
Willing to take photos of the application area before wear, daily during wear, and immediately after removal.
Willingness to report current known pregnancy.
Exclusion Criteria:
Unable to comply with the study protocol and instructions for wearing the devices for up to 15 days.
Any pre-existing breached or compromised skin, skin rash, irritation or infection at the application area.
Any incision, wound or scar in the application area.
Participants with known skin allergies and sensitivities to adhesives.
Participants with scheduled electronic imaging (including magnetic resonance imaging), cardioversion, and/or procedures where device would be removed during the data collection period.
Participants with known history of cardiac arrhythmias.
Participants with chest anatomies not compatible with secure parasternal placement.
Use of clothing or garment that can dislodge or loosen the patch or bras with underwires or other worn items that might interfere with the devices under study.